Samsung Bioepis Raises Fresh Questions For Biosimilar Interchangeability
At Least Two Of Eight Humira Biosimilars May Carry Designation
Acknowledging that “different companies have different views and approaches about interchangeability,” Samsung Bioepis has once again called into question the controversial designation.
